Evaluation of Monocyte Expression of HLA-DR (mHLA-DR) in Geriatric Service | MicrobiomeTrials← Back to trialsNCT06513520
Evaluation of Monocyte Expression of HLA-DR (mHLA-DR) in Geriatric Service
CompletedOBSERVATIONAL
Trial Details
Start: 2025-01-06Est. Completion: 2025-06-23
Enrollment target: 81 participants Locations- Dugoujon Hospital, Caluire-et-Cuire, France
- Croix Rousse hospital, Lyon, France
Other microbiome trials you might be interested in
Vaccine ReactionZosterSystemic Lupus Erythematosus
The goal of this observational study is to compare the vaccine response to the 2 doses of the adjuvanted herpes zoster s…
Seoul, South KoreaEst. completion Oct 1, 2030
Diabetes Mellitus, Type 1Hypoglycemia Unawareness
This is a prospective randomized placebo-controlled double-blind crossover pilot study determining the effect of dichlor…
New Haven, United StatesEst. completion May 1, 2027
Phase 1
Recruiting
Refractory/Relapsed Systemic Lupus ErythematosusRefractory / Relapsed / Progressive Systemic SclerosisRefractory / Relapsing / Progressive Inflammatory MyopathyRefractory / Relapsed Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated VasculitisRefractory / Relapsed Connective Tissue Disease-Associated Thrombocytopenia
This study is a single-arm, intervention, dose-escalation clinical trial to evaluate the safety of allogeneic CD19/BCMA-…
Multiple LocationsEst. completion Dec 31, 2028